Aquestive Therapeutics Stock Price

0.09 (2.1%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Aquestive Therapeutics Inc AQST NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.25 -5.51% 4.29 4.20 4.55 4.55 4.54 00:00:03
Bid Price Ask Price Spread Spread % News
4.38 4.59 0.21 4.58% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,522 581,279 $ 4.38 $ 2,545,684 809,802 1.41 - 10.00
Last Trade Time Type Quantity Stock Price Currency
19:56:09 76 $ 4.38 USD

Aquestive Therapeutics Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 144.07M 33.58M 19.43M $ 52.61M $ - -2.61 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -151.02k 6.70%

more financials information »

Aquestive Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AQST Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.894.904.204.61592,491-0.60-12.27%
1 Month4.995.924.205.04757,088-0.70-14.03%
3 Months3.846.923.455.241,038,1690.4511.72%
6 Months6.677.191.414.58838,505-2.38-35.68%
1 Year4.8110.001.415.16666,619-0.52-10.81%
3 Years15.0520.69611.416.00411,594-10.76-71.5%
5 Years15.0520.69611.416.00411,594-10.76-71.5%

Aquestive Therapeutics Description

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. The product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS). Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, and Zuplenz. The products pipeline includes Exservan Oral Film, Libervant Buccal Film, AQST-119, AQST-108, and AQST-305.

Your Recent History
Aquestive ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.